Sy Mukherjee
Associate EditorSayak "Sy" Mukherjee is a former Associate Editor at Industry Dive, managing and writing content for BioPharma Dive and occasionally contributing to sister publication Healthcare Dive. Raised in sunny Orange County, CA, Sy is an avid fan of the Los Angeles Lakers, Green Bay Packers, movies, TV, music, and cooking. He received an A.B. from Dartmouth College in June 2012, double majoring in government (with a focus on public policy) and religious studies. Sy worked as a health reporter for ThinkProgress.org for a year and a half after graduating before joining Industry Dive in July 2014.
366 articles by Sy Mukherjee
-
Sanofi cashes in $245M review voucher to leapfrog Novo in crucial diabetes combo race
Feb. 24, 2016 -
Jury orders J&J to pay patient's family $72M in talcum powder-ovarian cancer case
Feb. 24, 2016 -
Double whammy: Valeant stock hammered on Philidor accounting issues, CVS Jublia restrictions
Feb. 23, 2016 -
Bayer to name new CEO to replace chief exec who transformed firm: report
Feb. 22, 2016 -
Biotech pioneer Alfred Mann resigns as Executive Chairman of struggling MannKind
Feb. 19, 2016 -
Cipla snatches 1st US manufacturing plant as part of 'landmark acquisition'
Feb. 18, 2016 -
Chasing blockbusters: Does pharma need to change its success strategy?
Feb. 18, 2016 -
One Louisiana doc's made millions blowing the whistle on big pharma. Is that problematic?
Feb. 18, 2016 -
UPDATE: AstraZeneca & Daiichi rebuff Vermont governor's call to pull OIC Super Bowl ad
Feb. 17, 2016 -
Aegerion chopping 25% of its workforce in global reorg, eyes pipeline growth
Feb. 12, 2016 -
India's Ipca slammed by FDA for litany of severe data violations
Feb. 11, 2016 -
Report: Walgreens threatened to dissolve Theranos arrangement barring quick fixes
Feb. 11, 2016 -
After strong FDA panel backing, Celltrion & Pfizer's Remicade copycat could become 2nd US biosim
Feb. 10, 2016 -
Obama budget's $825 million NIH boost could hit big snags over funding structure
Feb. 10, 2016 -
In blow to Sanofi, UK's NICE reverses course & backs Amgen's PCSK9 med
Feb. 9, 2016 -
Update: After patient deaths, FDA puts CTI BioPharma's myelofibrosis on full clinical hold
Feb. 8, 2016 -
UPDATE: Feds give Theranos one more week to respond to damaging CMS inspection
Feb. 5, 2016 -
How top Valeant & Turing execs defended their drug prices to Congress on Thursday
Feb. 5, 2016 -
Liability: The big biosim legal scuffle the industry should be anticipating
Feb. 4, 2016 -
Martin Shkreli goes to Washington—and refuses to say anything to Congress
Feb. 4, 2016 -
Senators urge Obama to ramp up pressure against high drug prices
Feb. 3, 2016 -
With steady Q4 earnings in hand, Glaxo chief requests 3 years for more consumer unit profits
Feb. 3, 2016 -
2016 sees its first US IPOs as biotechs Editas, BeiGene enter a turbulent market
Feb. 3, 2016 -
Pfizer's Q4 mixed bag spotlights its pipeline dilemma
Feb. 2, 2016 -
UK scientists win regulatory clearance to edit human embryo genes in CRISPR-Cas9 milestone
Feb. 1, 2016